13. Older Adults: Standards of Medical Care in Diabetes-2022

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2021 Dec 29

PMID 34964847

Citations 81

Affiliations

Soon will be listed here.

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Citing Articles

Potential overtreatment in elderly patients with diabetes mellitus: Results from a cross-sectional study in German general practice.

Weise S, Oelschlager C, Unverzagt S, Abendroth J, Heise M, Frese T Eur J Gen Pract. 2025; 31(1):2447723.

PMID: 39964188 PMC: 11837937. DOI: 10.1080/13814788.2024.2447723.

Association of glycemic control with Long COVID in patients with type 2 diabetes: findings from the National COVID Cohort Collaborative (N3C).

Soff S, Yoo Y, Bramante C, Reusch J, Huling J, Hall M BMJ Open Diabetes Res Care. 2025; 13(1).

PMID: 39904520 PMC: 11795369. DOI: 10.1136/bmjdrc-2024-004536.

The association of muscle weakness with functional disability in older patients with Diabetes mellitus: Measured by three different grip strength thresholds.

Cavdar S, Kayhan Kocak F, Savas S PLoS One. 2025; 20(1):e0317250.

PMID: 39883612 PMC: 11781639. DOI: 10.1371/journal.pone.0317250.

Minimising harms of tight glycaemic control in older patients with type 2 diabetes.

Thompson W Afr J Prim Health Care Fam Med. 2025; 16(1):e1-e4.

PMID: 39846108 PMC: 11736572. DOI: 10.4102/phcfm.v16i1.4857.

A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications.

Pilla S, Wang I, Tang O, Schoenborn N, Boyd C, Bancks M Clin Diabetes. 2025; 43(1):33-42.

PMID: 39829686 PMC: 11739336. DOI: 10.2337/cd24-0043.

References

Davies M, DAlessio D, Fradkin J, Kernan W, Mathieu C, Mingrone G . Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018; 41(12):2669-2701. PMC: 6245208. DOI: 10.2337/dci18-0033. View

Husain M, Birkenfeld A, Donsmark M, Dungan K, Eliaschewitz F, Franco D . Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2019; 381(9):841-851. DOI: 10.1056/NEJMoa1901118. View

Gregg E, Chen H, Wagenknecht L, Clark J, Delahanty L, Bantle J . Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2013; 308(23):2489-96. PMC: 4771522. DOI: 10.1001/jama.2012.67929. View

Yaffe K, Falvey C, Hamilton N, Schwartz A, Simonsick E, Satterfield S . Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012; 69(9):1170-5. PMC: 3752423. DOI: 10.1001/archneurol.2012.1117. View

Pratley R, Kanapka L, Rickels M, Ahmann A, Aleppo G, Beck R . Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020; 323(23):2397-2406. PMC: 7298607. DOI: 10.1001/jama.2020.6928. View

Craft S, Baker L, Montine T, Minoshima S, Watson G, Claxton A . Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2011; 69(1):29-38. PMC: 3260944. DOI: 10.1001/archneurol.2011.233. View

Roberts R, Knopman D, Przybelski S, Mielke M, Kantarci K, Preboske G . Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology. 2014; 82(13):1132-41. PMC: 3966799. DOI: 10.1212/WNL.0000000000000269. View

Espeland M, Rejeski W, West D, Bray G, Clark J, Peters A . Intensive weight loss intervention in older individuals: results from the Action for Health in Diabetes Type 2 diabetes mellitus trial. J Am Geriatr Soc. 2013; 61(6):912-922. PMC: 4123658. DOI: 10.1111/jgs.12271. View

Pilla S, Schoenborn N, Maruthur N, Huang E . Approaches to Risk Assessment Among Older Patients With Diabetes. Curr Diab Rep. 2019; 19(8):59. PMC: 7307417. DOI: 10.1007/s11892-019-1172-z. View

10.

Bradley M, Chillarige Y, Lee H, Wu X, Parulekar S, Muthuri S . Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin. JAMA Intern Med. 2021; 181(5):598-607. PMC: 7922234. DOI: 10.1001/jamainternmed.2020.9176. View

11.

Dorner B, Friedrich E, Posthauer M . Practice paper of the American Dietetic Association: individualized nutrition approaches for older adults in health care communities. J Am Diet Assoc. 2010; 110(10):1554-63. DOI: 10.1016/j.jada.2010.08.023. View

12.

Kirkman M, Jones Briscoe V, Clark N, Florez H, Haas L, Halter J . Diabetes in older adults. Diabetes Care. 2012; 35(12):2650-64. PMC: 3507610. DOI: 10.2337/dc12-1801. View

13.

Gencer B, Marston N, Im K, Cannon C, Sever P, Keech A . Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020; 396(10263):1637-1643. PMC: 8015314. DOI: 10.1016/S0140-6736(20)32332-1. View

14.

Fitzgerald J, Davis W, Connell C, HESS G, Funnell M, HISS R . Development and validation of the Diabetes Care Profile. Eval Health Prof. 1996; 19(2):208-30. DOI: 10.1177/016327879601900205. View

15.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

16.

Lipska K, Ross J, Miao Y, Shah N, Lee S, Steinman M . Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015; 175(3):356-62. PMC: 4426991. DOI: 10.1001/jamainternmed.2014.7345. View

17.

Munshi M, Slyne C, Segal A, Saul N, Lyons C, Weinger K . Simplification of Insulin Regimen in Older Adults and Risk of Hypoglycemia. JAMA Intern Med. 2016; 176(7):1023-5. DOI: 10.1001/jamainternmed.2016.2288. View

18.

Abdelhafiz A, Sinclair A . Deintensification of hypoglycaemic medications-use of a systematic review approach to highlight safety concerns in older people with type 2 diabetes. J Diabetes Complications. 2017; 32(4):444-450. DOI: 10.1016/j.jdiacomp.2017.11.011. View

19.

Sinclair A, Morley J, Rodriguez-Manas L, Paolisso G, Bayer T, Zeyfang A . Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in.... J Am Med Dir Assoc. 2012; 13(6):497-502. DOI: 10.1016/j.jamda.2012.04.012. View

20.

Leung E, Wongrakpanich S, Munshi M . Diabetes Management in the Elderly. Diabetes Spectr. 2018; 31(3):245-253. PMC: 6092888. DOI: 10.2337/ds18-0033. View